Pressotherapy for Athletes: Recovery and Performance Benefits

Pressotherapy has a real place in athletic recovery conversations, but the actual research supports a more measured picture than "speeds up recovery" marketing often implies.

What the strongest evidence actually shows

A systematic review and meta-analysis, following PRISMA guidelines, screened studies through March 2021 and selected 12 randomized controlled or cross-over trials comprising 322 participants. The average study size was 25 participants.

The finding: pressotherapy significantly reduced muscle soreness overall, with a standardized mean difference of -0.33 and a p-value below 0.0001 — a statistically robust result across the pooled data, using devices like the Pressotherapy Lymphatic Massage Device.

What it honestly does NOT show

The same review found pressotherapy did not significantly affect creatine kinase levels — an objective blood biomarker of muscle damage — measured from 24 to 96 hours after exercise-induced soreness was induced.

Importantly, this soreness reduction wasn't universal across every study protocol included in the review. Some individual groups showed no significant reduction in soreness at all, meaning the overall positive result reflects the pooled average, not a guaranteed effect in every application.

An honest skepticism worth including — from the researchers themselves

This is worth stating plainly, since it's easy to skip in marketing content: the review's own authors noted there are relatively few compelling arguments for the wide adoption of pressotherapy specifically, given that cheaper, more accessible, and self-applicable alternatives — stretching, foam-rolling, cold therapy, water immersion, and simple rest — can achieve broadly comparable soreness-reduction benefit.

This doesn't mean pressotherapy offers nothing. It means the case for it as a uniquely superior recovery tool, compared to much lower-cost alternatives, isn't strongly supported by this specific body of evidence.

Newer research worth knowing about

More recent research specifically in combat sports athletes found pneumatic compression and cryo-compression therapies produced significant improvements in tissue perfusion and muscle elasticity compared to passive rest. This is genuinely newer, more specific evidence — worth citing separately from the broader 2022 meta-analysis rather than blending the two.

A separate, ongoing area of research is examining intermittent pneumatic compression specifically for muscle fatigue recovery across a larger pool of studies — an active, still-developing evidence base rather than a single settled conclusion.

What this means practically for your athletic clients

The genuine, evidence-supported benefit is reduced subjective soreness in the days following intense exercise. This is a real, worthwhile outcome for client comfort and satisfaction, even though it doesn't extend to objectively measured muscle damage markers or, according to the review's own authors, clearly outperform much cheaper recovery methods.

Where it fits in a responsible recovery offering

Positioning pressotherapy as one comfortable, genuinely soreness-reducing option within a broader recovery menu — rather than the single essential tool athletes need — reflects the evidence honestly. Pairing it with equipment like the 30K/40K Cavitation Device for clients with broader body composition goals alongside recovery needs reflects a genuinely complementary service menu, not a single recovery-only offering.

The bottom line

Pressotherapy has real, statistically significant evidence for reducing subjective muscle soreness in athletes — a genuine, worthwhile benefit. It's honestly not shown to reduce objective muscle damage biomarkers, and the researchers behind the strongest available evidence themselves questioned whether it clearly justifies its cost and adoption over much cheaper, comparably effective alternatives.

Back to blog